-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
Freeline Therapeutics Holdings plc quarterly/annual Depreciation, Depletion and Amortization history and growth rate from Q1 2020 to Q1 2023.
- Freeline Therapeutics Holdings plc Depreciation, Depletion and Amortization for the quarter ending March 31, 2023 was $320K, a 40.9% decline year-over-year.
- Freeline Therapeutics Holdings plc annual Depreciation, Depletion and Amortization for 2022 was $1.74M, a 27.2% decline from 2021.
- Freeline Therapeutics Holdings plc annual Depreciation, Depletion and Amortization for 2021 was $2.39M, a 24.9% increase from 2020.
- Freeline Therapeutics Holdings plc annual Depreciation, Depletion and Amortization for 2020 was $1.91M, a 24.2% increase from 2019.
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)